fig3

Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis

Figure 3. RT-PCR analysis of the NR6A1 expression in ERα-positive MCF-7, MCF-7/T, and MCF-7/Rap cells (A), and ERα-negative MDA-MB-231 cell line (B); ****P < 0.0001, ***P < 0.001 (t-test was used to compare two sample means).

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/